Skip to content

Research on the management of symptoms in the whole life cycle of rheumatism children based on the nursing precision health model

Research on the management of symptoms in the whole life cycle of rheumatism children based on the nursing precision health model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102885
Enrollment
Unknown
Registered
2025-05-21
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatic immune diseases in children

Interventions

Observation group:None

Sponsors

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 8-18 years who were diagnosed with rheumatism according to the diagnostic criteria for common rheumatism in children in 2010. 2. Normal cognitive function, can read and write normally, have the ability to complete the questionnaire independently; 3. Informed consent of children and their parents.

Exclusion criteria

Exclusion criteria: 1. Serious diseases of other important organs such as diabetes or cardiovascular disease; 2. Incomplete medical reports; 3. Combine with other systemic inflammatory diseases and use anti-inflammatory therapy within 3 months.

Design outcomes

Primary

MeasureTime frame
PROMIS pediatric-25 profile V2.0;

Secondary

MeasureTime frame
Health Behaviour School-aged Children;Children’s Sleep Habits Questionnaire, CSHQ;STARx Self-management and Transition Readiness Assessment (Chinese Version of STARx Scale);

Countries

China

Contacts

Public ContactShenbiyu

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

shenbiyu@126.com+86 138 6293 7317

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026